B Cell Immunology Partnership Program For HIV-1 Vaccine Discovery (U19)

Post Date

June 16th 2009

Application Due Date

December 4th 2009

Funding Opportunity Number

RFA-AI-09-022

CFDA Number(s)

93.855
93.856

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Estimated Total Funding:

  $3000000

• Award Range:

  $None - $1000000

Grant Description

Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, (NIH) solicits grant applications from institutions/organizations that propose multidisciplinary research to define the basic immune mechanisms by which a broadly cross-reactive neutralizing antibody response can be elicited in uninfected individuals to protect against infection by a broad range of HIV-1 strains. Specifically, this FOA will support innovative studies to identify new HIV-1 envelope immunogens and immunization strategies for induction of broadly cross-reactive neutralizing antibody, and basic B cell immunology research designed to increase fundamental knowledge of the immunological mechanisms involved in the induction and regulation of immune responses leading to an HIV-1 broadly cross-reactive neutralizing antibody response. Preliminary data are required, and expertise in basic immunology and the HIV-1 virus should be evident. This multi-project cooperative agreement grant program will support a partnership to communicate ideas and progress among recipients of U19 awards as well as recipients of previous U01 awards issued under B Cell Immunology for Protective HIV-1 Vaccines (RFAAI-07-014). Clinical trials will not be supported by this FOA.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-09-022.html